Meet PBC’s President Linda Cahn

Pharmacy Benefit Consultants was founded by Attorney Linda Cahn. Since its founding, PBC has worked with numerous entities — including private corporations, unions, insurance companies and coalitions — to decrease their drug benefit costs and improve their drug benefit coverage.

Linda Cahn’s experience uniquely positions her to advise drug benefit purchasers. In 1997, Linda initiated the first class action litigation against pharmaceutical benefit management companies (”PBMs”). Her lawsuits alleged that the two largest PBMs at the time - Medco Health Solutions, Inc. (”Medco”) and PCS Health Systems, Inc. (”PCS”) - had breached their ERISA fiduciary duties to employee benefit plans across the country, increasing plans’ drug benefit costs.

Since 1997, Linda has been deeply involved in consulting and litigating on drug benefit and pricing issues. As a result, she has reviewed hundreds of confidential contracts between PBMs and their clients, scores of RFPs, and hundreds of thousands of confidential internal PBM documents revealing how PBMs create profit margins and thereby increase their clients’ costs.

For more than seven years, Linda has also conducted meetings with federal and state officials on Capitol Hill, at the Government Accounting Office (GAO), at the U.S. Labor Department, in federal prosecutors’ offices, and in numerous state attorney general offices. She has also testified before State Legislative Hearings, and worked with State Legislators to draft legislation to improve the PBM marketplace. Her work has educated prosecutors and legislators about drug benefit and pricing issues and generated investigations of the PBM industry.

Believing that corporate America and labor unions must also be educated about pharmaceutical benefit and pricing issues, Linda has given numerous presentations on drug pricing issues across the country, including at national conventions. She has also worked with reporters from the national and local media. As a result, in-depth stories have appeared in numerous newspapers, magazines and on the radio, including the New York Times, Wall Street Journal, Newsweek, the Newark Star Ledger and NPR.

Linda has also worked with executives and trustees of Fortune 50 and smaller companies, insurance companies, unions, government representatives and coalition executives to review their PBM contracts, analyze why their drug costs are continuously increasing, conduct RFPs, and negotiate and draft new contracts to improve their drug benefits and decrease their costs. Meanwhile, Linda continues to represent private entities in litigation against their PBMs, acquiring still further knowledge about PBM contracts and activities.